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Background:  Cardiac involvement by light-chain amyloid occurs in up to 50% of patients with primary amyloidosis. The prognosis of 
amyloid heart disease is particularly poor with dismal one-year survival rates of 35-40%. Herein, we present a unique case where bridging 
total artificial heart prior to heart transplantation was performed to allow eventual stem cell transplantation.
case:  A 48 year-old male was evaluated for atypical chest pain. Physical examination revealed a diastolic murmur. Echocardiogram 
confirmed a bicuspid aortic valve with moderate insufficiency and severe concentric left ventricular hypertrophy (LVH). The EKG displayed 
normal voltage. Together, these disparate findings were concerning for an infiltrative process. Cardiac MR confirmed diffuse subendocardial 
enhancement most consistent with cardiac amyloidosis. Laboratory studies demonstrated elevated lambda light chains. Bone marrow 
biopsy showed plasmacytosis (15%) with positive Congo red staining. Cardiac amyloidosis was presumed. Over the next 3 months, the 
patient was hospitalized 3 times for decompensated heart failure (HF). Serial echocardiograms established rapidly worsening LV systolic 
function. Recognizing the rapid deterioration of cardiac performance despite optimal medical therapy, an urgent referral was placed 
to a center with advanced heart failure capabilities. Shortly thereafter, the patient suffered an out-of-hospital cardiac arrest. He was 
resuscitated, stabilized, and transferred to Cedars-Sinai Medical Center in Los Angeles. Within 2 weeks, he received a Syncardia® total 
artificial heart. 6 months later, he underwent successful orthotopic heart and kidney transplantation. He is now undergoing treatment for AL 
amyloidosis with plans for stem cell transplant.
conclusion:  This case illustrates an instance where urgent referral to a center for advanced heart failure altered his survival. Given his 
poor prognosis this patient’s best chance at survival and ongoing treatment was by receiving a total artificial heart. The decision to escalate 
the patient’s care led directly to improved length and quality of life.
